Anti-TNF Kontrollü Salım Sisteminin Romatoid Artirit Tedavilerine Yönelik Etkilerinin Hücre Kültüründe İncelenmesi

Download
2012
Özen, Seza
Tezcaner, Ayşen
Keskin, Dilek Esra
Usanmaz, Ali
Atilla, Bülent
Anti-TNFα drugs for rheumatoid arthritis treatment show comprehensive effect against inflammation with their ability to reduce significantly TNFα and other proinflammatory cytokine production. However, there are some restrictions for anti-TNFα treatment because of long-term usage and toxic effects. Intraarticularly injectable polycaprolactone (PCL) and PEGylated polycaprolactone (PEGPCL-PEG) microspheres releasing anti-TNFα for more than 3 months, were prepared and their effectiveness in treatment were examined with in vitro studies. PEG-PCL-PEG was synthesized from PEG-PCL diblock copolymer using coupling agent. Immunoglobulin G was used to for optimization studies. Particle size of anti-TNFα loaded PCL and PEG-PCL-PEG microspheres was 5 μm and microspheres had high encapsulation efficiencies (65.37 ± 1.80 % and 75.91 ± 1.16 %, respectively). Biologically active drug release during 3 months was observed for each group. Anti-TNFα loaded microspheres and free anti-TNFα were incubated with synoviocytes isolated from RA patients for 1 month and time-dependent changes in the quantity and mRNA expression levels of the proinflomatory cytokines (TNF-α, IL-6, IL-17 ve IFN-γ) and matrix metalloproteases (MMP) 3 and 13 were investigated by ELISA and PCR methods. Levels of cytokines and MMPs released from synoviocytes incubated with anti-TNFα loaded microspheres were significantly lower than that of released free anti-TNFα group.MMP-3 and IL6 gene expressions of synoviocytes incubated with microspheres were upregulated at week2 whereas MMP-13 gene of synoviocytes incubated with free drug was upregulated at week3. At other time points, no change was observed. According to the results, potential usage of PCL and PEG-PCL-PEG controlled release systems in clinical applications is high

Suggestions

Development of novel controlled release formulations of anti-tnf for rheumatoid arthritis and modeling of release behaviors
Erdemli, Özge; Tezcaner, Ayşen; Keskin, Dilek; Department of Engineering Sciences (2013)
Anti-TNFα drugs are widely used in treatment of rheumatoid arthritis. However, long term use of these drugs involves systemic effects. New era in medication involves controlled delivery systems that will provide local sustained release of drug. This study aims to develop a novel intra-articularly injectable etanercept (ETN) loaded poly(ε-caprolactone) (PCL) or methoxypoly(ethyleneglycol)-poly(ε-caprolactone)-methoxypoly(ethyleneglycol) (MPEG-PCL-MPEG) microspheres (patent pending) for the treatment of chron...
Development and characterization of cortisone derivative drugcarrying polymeric microspheres
Öcal, Yiğit; Keskin, Dilek; Özen, Seza; Department of Biomedical Engineering (2011)
In this study, it is aimed to develop an injectable controlled release system of PCL and P(L,DL)LA microspheres loaded with TA and/or Ral for local treatment of rheumatoid arthritis which will avoid from systemic side effects of traditional administration and eliminate problems caused by direct local injections. Rheumatoid arthritis (RA) is a chronic, systemic, autoimmune disorder that most commonly causes inflammation and tissue damage in joints and tendon sheaths. Current strategies for the disease are ma...
Investigation of docetaxel and doxorubicin resistance in mcf-7 breast carcinoma cell line
Darcansoy İşeri, Özlem; Gündüz, Ufuk; Department of Biotechnology (2009)
Multidrug resistance phenotype of tumor cells describes resistance to wide range of structurally unrelated anticancer agents and is a serious limitation to effective chemotherapy. It is a multifactor yet not fully elucidated phenomenon by the involvement of diverse cellular pathways. Aim of this study was to investigate the resistance mechanisms developed against docetaxel and doxorubicin that are widely used in the treatment of breast cancer in model cell line MCF-7. Resistant sublines were developed by ap...
Synthesis of poly (dl-lactic-co-glycolic acid) coated magnetic nanoparticles for anti-cancer drug delivery
Tansık, Gülistan; Gündüz, Ufuk; Department of Biology (2012)
One of the main problems of current cancer chemotherapy is the lack of selectivity of anti-cancer drugs to tumor cells which leads to systemic toxicity and adverse side effects. In order to overcome these limitations, researches on controlled drug delivery systems have gained much attention. Nanoscale based drug delivery systems provide tumor targeting. Among many types of nanocarriers, superparamagnetic nanoparticles with their biocompatible polymer coatings can be targeted to an intented site by an extern...
New Protocol for Scanning Minor and Major Grooves Along DNA to Find Best Interaction Mode With Drug Molecules
Gülkaya, Aybüke; Marıon, Antoıne; Department of Chemistry (2022-1-18)
Major and minor groove binder drugs could function as possible treatment agents in genetic disorders or cancer. DNA is recognized by different proteins during replication, translation, and transcription. Basically, by binding to the grooves of DNA, small drug molecules can change the helical structure of DNA, interfere with protein binding and prevent replication, translation or transcription. To alter and inhibit DNA - protein interactions, especially sequence specific ligands should be designed. Accordin...
Citation Formats
S. Özen, A. Tezcaner, D. E. Keskin, A. Usanmaz, and B. Atilla, “Anti-TNF Kontrollü Salım Sisteminin Romatoid Artirit Tedavilerine Yönelik Etkilerinin Hücre Kültüründe İncelenmesi,” 2012. Accessed: 00, 2020. [Online]. Available: https://app.trdizin.gov.tr/publication/project/detail/TVRVNE9URXg.